We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPE
4551
Special Opportunities Fund
SPE
$141M
$424K ﹤0.01%
39,385
-42,077
-52% -$418K
TTCF
4552
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$424K ﹤0.01%
+25,758
New +$316K
ASND icon
4553
Ascendis Pharma A/S
ASND
$16B
$422K ﹤0.01%
2,854
+520
+22% +$71.4K
SPYX icon
4554
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.79B
$422K ﹤0.01%
16,596
+5,268
+47% +$127K
HYB
4555
DELISTED
New America High Income Fund, Inc.
HYB
$420K ﹤0.01%
53,944
-18,755
-26% -$142K
VAPO
4556
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$419K ﹤0.01%
1,277
+551
+76% +$116K
CLCT
4557
DELISTED
Collectors Universe
CLCT
$418K ﹤0.01%
12,210
+11,015
+922% +$250K
PXI icon
4558
Invesco Dorsey Wright Energy Momentum ETF
PXI
$51.6M
$417K ﹤0.01%
27,471
+19,138
+230% +$278K
TRIB
4559
Trinity Biotech
TRIB
$7.51M
$417K ﹤0.01%
1,277
+893
+233% +$204K
AMRX icon
4560
Amneal Pharmaceuticals
AMRX
$6.02B
$415K ﹤0.01%
87,190
-8,905
-9% -$36.7K
FBNC icon
4561
First Bancorp
FBNC
$2.64B
$415K ﹤0.01%
16,551
-11,917
-42% -$287K
LCNB icon
4562
LCNB Corp
LCNB
$282M
$413K ﹤0.01%
25,877
+4,265
+20% +$58.8K
CABA icon
4563
Cabaletta Bio
CABA
$439M
$412K ﹤0.01%
36,987
+31,386
+560% +$240K
DAY
4564
DELISTED
Dayforce
DAY
$412K ﹤0.01%
5,199
-889,361
-99% -$57.1M
PBPB
4565
DELISTED
Potbelly
PBPB
$411K ﹤0.01%
180,665
+161,321
+834% +$442K
ESBK
4566
DELISTED
Elmira Savings Bank Elmira NY
ESBK
$410K ﹤0.01%
37,309
+800
+2% +$9.42K
SWI
4567
DELISTED
SolarWinds Corporation Common Stock
SWI
$410K ﹤0.01%
22,009
+17,159
+354% +$316K
NEN icon
4568
New England Realty Associates
NEN
$196M
$409K ﹤0.01%
7,733
+3,700
+92% +$175K
NNVC icon
4569
NanoViricides
NNVC
$39.5M
$409K ﹤0.01%
54,631
+8,154
+18% +$56.7K
KORP icon
4570
American Century Diversified Corporate Bond ETF
KORP
$883M
$405K ﹤0.01%
+7,758
New +$395K
ROM icon
4571
ProShares Ultra Technology
ROM
$1.16B
$403K ﹤0.01%
17,256
+11,856
+220% +$227K
CLMT icon
4572
Calumet Specialty Products
CLMT
$3.69B
$402K ﹤0.01%
176,329
-390,107
-69% -$834K
GORO icon
4573
Goldgroup Mining Inc.
GORO
$164M
$401K ﹤0.01%
97,653
+17,275
+21% +$66.6K
KOPN icon
4574
Kopin
KOPN
$693M
$401K ﹤0.01%
301,492
+229,964
+322% +$193K
VPG icon
4575
Vishay Precision Group
VPG
$1.22B
$401K ﹤0.01%
16,320
+7,164
+78% +$161K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.